Signa Sa De Cv, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NADOLOL USP, with a corresponding US DMF Number 7426.
Remarkably, this DMF maintains an Active status since its submission on April 11, 1988, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 24, 2015, and payment made on August 07, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II